Bio-Techne Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	172.88	162.19	151.79	180.57	172.57	199.09
Short-Term Investments	6.67	-	1.07	23.74	74.46	32.46
Cash & Short-Term Investments	179.55	162.19	152.86	204.31	247.03	231.55
Cash Growth	1.12%	6.10%	-25.18%	-17.29%	6.68%	-14.52%
Receivables	184.61	206.88	241.39	218.47	194.55	145.39
Inventory	205.45	189.45	179.73	171.64	141.12	116.75
Other Current Assets	67.83	49.79	43.43	27.07	22.86	16.92
Total Current Assets	637.43	608.3	617.42	621.48	605.56	510.61
Property, Plant & Equipment	302.63	319.12	342.44	324.53	288.8	281.74
Long-Term Investments	250.04	253.83	252.15	272.71	36.03	0.28
Goodwill	980.56	980.94	972.66	872.74	822.1	843.07
Other Intangible Assets	334.99	365.6	507.08	534.65	531.52	615.97
Long-Term Deferred Tax Assets	-	10.31	-	-	-	-
Other Long-Term Assets	17.05	19.78	12.12	12.59	10.8	11.3
Total Assets	2,523	2,558	2,704	2,639	2,295	2,263
Accounts Payable	26.27	25.31	37.97	25.68	33.87	29.38
Accrued Expenses	64.4	90.35	74.7	51.63	79.84	66.58
Current Portion of Long-Term Debt	-	-	-	-	12.98	13.28
Current Portion of Leases	13.71	14.1	12.92	11.2	11.93	11.6
Current Income Taxes Payable	2.48	10.77	3.71	12.02	13.24	5.34
Current Unearned Revenue	31.03	32.57	27.93	23.07	23.41	19
Other Current Liabilities	2.54	2.75	2.15	4.91	0.77	7.12
Total Current Liabilities	140.43	175.85	159.38	128.51	176.02	152.28
Long-Term Debt	260	346	319	350	243.41	336.43
Long-Term Leases	77.19	83.96	87.62	93.77	58.13	67.63
Long-Term Unearned Revenue	1.97	2.73	2.27	1.53	2.09	1.01
Long-Term Deferred Tax Liabilities	11.02	6.17	55.86	88.98	98.99	93.13
Other Long-Term Liabilities	21.11	24.35	10.89	9.39	15.15	41.26
Total Liabilities	511.71	639.06	635.02	672.18	593.79	691.72
Common Stock	1.56	1.55	1.58	1.58	1.57	0.39
Additional Paid-In Capital	964.96	911.09	820.34	721.54	652.47	534.41
Retained Earnings	1,107	1,066	1,325	1,309	1,123	1,085
Comprehensive Income & Other	-62.34	-59.88	-78.32	-66.06	-75.2	-57.29
Total Common Equity	2,011	1,919	2,069	1,967	1,702	1,563
Minority Interest	-	-	-	-	-0.76	8.26
Shareholders' Equity	2,011	1,919	2,069	1,967	1,701	1,571
Total Liabilities & Equity	2,523	2,558	2,704	2,639	2,295	2,263
Total Debt	350.9	444.06	419.54	454.97	326.45	428.93
Net Cash (Debt)	-171.35	-281.87	-266.68	-250.66	-79.42	-197.38
Net Cash Per Share	-1.09	-1.76	-1.66	-1.55	-0.48	-1.22
Filing Date Shares Outstanding	156.45	155.55	158.6	158.17	156.85	156.32
Total Common Shares Outstanding	155.88	154.97	158.22	157.64	156.64	155.82
Working Capital	497.01	432.45	458.04	492.97	429.54	358.32
Book Value Per Share	12.90	12.38	13.08	12.47	10.86	10.03
Tangible Book Value	695.44	572.27	589.11	559.13	348.15	103.94
Tangible Book Value Per Share	4.46	3.69	3.72	3.55	2.22	0.67
Land	8.15	8.15	8.15	9.1	8.57	8.61
Buildings	257.99	254.36	243.86	245.3	229.55	190.66
Machinery	241.98	245.92	215.95	190.02	174.81	149.41
Construction In Progress	19.38	23.42	39.75	15.49	21.73	49.07

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q